Private company
Wilson Therapeutics
Logo: Wilson Therapeutics company representative, Non-free logo, via Wikipedia4
Swedish biopharmaceutical company
Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for rare diseases. The company is listed in the Mid-Cap segment on Nasdaq Stockholm with the stock ticker WTX. Wilson Therapeutics' lead product, Decuprate, is the proprietary bis-choline salt of tetrathiomolybdate.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industrypharmaceutical industry1
- HeadquartersStockholm1
- Websitewww.wilsontherapeutics.com
- Legal formAktiebolag3
- LEI549300QZKRVR9SKRLC673
- StatusInactive3
- LEI statusRetired3
- Registered addressKungsgatan 3, 111 43 Stockholm, Sweden3
- Registered withSwedish Companies Registration Office, 556893-03573
See how the biggest companies compare on our leaderboards
Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for rare diseases. The company is listed in the Mid-Cap segment on Nasdaq Stockholm with the stock ticker WTX. Wilson Therapeutics' lead product, Decuprate, is the proprietary bis-choline salt of tetrathiomolybdate.2
Products and brands
- bis(choline)tetrathiomolybdate
Listed on Wikidata.1
Timeline
- 2012Founded Founded1
Links
- Websitewww.wilsontherapeutics.com1
- WikipediaWilson Therapeutics
- WikidataQ18395077
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataWilson Therapeutics on Wikidata
- 2WikipediaWilson Therapeutics on Wikipedia
- 3
- 4